HMS Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,716
Closed -$386K 121
2021
Q4
$386K Sell
1,716
-97
-5% -$20.5K 0.17% 101
2021
Q3
$386K Sell
1,813
-548
-23% -$126K 0.18% 106
2021
Q2
$576K Sell
2,361
-120
-5% -$29.5K 0.26% 76
2021
Q1
$617K Sell
2,481
-588
-19% -$140K 0.26% 60
2020
Q4
$706K Sell
3,069
-224
-7% -$51.6K 0.32% 66
2020
Q3
$837K Sell
3,293
-417
-11% -$103K 0.32% 57
2020
Q2
$875K Buy
3,710
+1,526
+70% +$348K 0.38% 58
2020
Q1
$443K Sell
2,184
-2,803
-56% -$612K 0.43% 52
2019
Q4
$1.2M Buy
4,987
+60
+1% +$13.2K 0.51% 50
2019
Q3
$953K Buy
4,927
+694
+16% +$133K 0.35% 82
2019
Q2
$780K Sell
4,233
-1,220
-22% -$218K 0.34% 72
2019
Q1
$1.04M Buy
5,453
+1,082
+25% +$207K 0.44% 66
2018
Q4
$851K Buy
+4,371
New +$853K 0.43% 71

Other funds holding AMGN

HMS Capital Management's AMGN Position: Q1 2022 in Review

HMS Capital Management sold out of Amgen (AMGN) in Q1 2022, closing a stake of 1,716 shares — an estimated $386K sold.

HMS Capital Management first reported a position in AMGN in Q4 2018 and held it in 13 quarters. The position peaked at $1.2M in Q4 2019. 2,337 funds tracked by Wall St. Rank hold AMGN as of Q1 2022.

  • HMS Capital Management reported no remaining Amgen position as of Q1 2022 after selling out during the quarter.
  • HMS Capital Management sold 1,716 Amgen shares in Q1 2022, an estimated $386K.
  • HMS Capital Management first reported a position in Amgen in Q4 2018 and held it in 13 quarters.
  • HMS Capital Management's Amgen position peaked at $1.2M in Q4 2019.
  • 2,337 funds tracked by Wall St. Rank held Amgen as of Q1 2022.

Based on HMS Capital Management's 13F filing for Q1 2022, filed 20 Apr 2022.